阿立哌唑(CAS 129722-12-9):分子式 C23H27Cl2N3O2、分子量 448.4。
| CAS号 | 129722-12-9 |
|---|---|
| 分子式 | C23H27Cl2N3O2 |
| 分子量 | 448.4 |
| 熔点 | 137-140 |
| 沸点 | 139.0-139.5 °C |
| LogP | 4.6 |
| 应用领域 | Uses: MEDICATION、Antipsychotic Agents、Use (kg、approx.) in Germany (2009): >100、Consumption (g per capita、approx.) in Germany (2009): 0.00122、Calculated removal (%): 85.2、For the treatment of schizophrenia and related psychotic disorders.、Methods of Manufacturing: 7-Hydroxy-3、4-dihydro-2(1H)-quinolinone is refluxed with 1、4-dibromobutane plus K2CO3 in DMF to form the 7-(4-bromobutoxy) derivative which is condensed with 1-(3、4-dichlorophenyl)piperazine to yield the product.、Preparation: Y. Oshiro et al.、European Patent Office patent 367141、eidem、United States of America patent 5006528 (1990、1991 both to Otsuka).、Formulations、Preparations: Table: Aripiprazole Preparations [Table#6911]、General Manufacturing Information: Information available in 2005 indicated that Aripiprazole was used in the manufacture of pharmaceutical preparations in the following countries: Australia、Germany、Mexico、Switzerland、United Kingdom、United States (1、2) |
登记用途:Uses: MEDICATION、Antipsychotic Agents、Use (kg、approx.) in Germany (2009): >100、Consumption (g per capita、approx.) in Germany (2009): 0.00122、Calculated removal (%): 85.2、For the treatment of schizophrenia and related psychotic disorders.、Methods of Manufacturing: 7-Hydroxy-3、4-dihydro-2(1H)-quinolinone is refluxed with 1、4-dibromobutane plus K2CO3 in DMF to form the 7-(4-bromobutoxy) derivative which is condensed with 1-(3、4-dichlorophenyl)piperazine to yield the product.、Preparation: Y. Oshiro et al.、European Patent Office patent 367141、eidem、United States of America patent 5006528 (1990、1991 both to Otsuka).、Formulations、Preparations: Table: Aripiprazole Preparations [Table#6911]、General Manufacturing Information: Information available in 2005 indicated that Aripiprazole was used in the manufacture of pharmaceutical preparations in the following countries: Australia、Germany、Mexico、Switzerland、United Kingdom、United States (1、2)。
阿立哌唑 是一种化工化合物,登记 CAS 号为 129722-12-9,分子式 C23H27Cl2N3O2(分子量 448.4)。
登记 CAS 号:129722-12-9
其分子式 C23H27Cl2N3O2 由 23 个碳、27 个氢、2 个氯、3 个氮、2 个氧 组成。
别名/同义词:阿立哌唑 · Aripiprazole
阿立哌唑 的 CAS 登记号为 129722-12-9。
分子式 C23H27Cl2N3O2,分子量 448.4。
别名/同义词:阿立哌唑、Aripiprazole。
登记用途:Uses: MEDICATION、Antipsychotic Agents、Use (kg、approx.) in Germany (2009): >100、Consumption (g per capita、approx.) in Germany (2009): 0.00122、Calculated removal (%): 85.2、For the treatment of schizophrenia and related psychotic disorders.、Methods of Manufacturing: 7-Hydroxy-3、4-dihydro-2(1H)-quinolinone is refluxed with 1、4-dibromobutane plus K2CO3 in DMF to form the 7-(4-bromobutoxy) derivative which is condensed with 1-(3、4-dichlorophenyl)piperazine to yield the product.、Preparation: Y. Oshiro et al.、European Patent Office patent 367141、eidem、United States of America patent 5006528 (1990、1991 both to Otsuka).、Formulations、Preparations: Table: Aripiprazole Preparations [Table#6911]、General Manufacturing Information: Information available in 2005 indicated that Aripiprazole was used in the manufacture of pharmaceutical preparations in the following countries: Australia、Germany、Mexico、Switzerland、United Kingdom、United States (1、2)。
阿立哌唑(CAS 129722-12-9)的独立参考数据,整理自公开化学数据库。
| CAS Registry Number | 129722-12-9 |
|---|---|
| PubChem CID | 60795 |
| Molecular formula | C23H27Cl2N3O2 |
| IUPAC name | 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one |
| UNII (FDA) | 82VFR53I78 |
| Molecular Weight | 448.4 |
|---|---|
| XLogP3 | 4.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 7 |
| Exact Mass | 447.1480325 |
| Monoisotopic Mass | 447.1480325 |
| Topological Polar Surface Area | 44.8 |
| Heavy Atom Count | 30 |
| Boiling Point | 139.0-139.5 °C |
|---|---|
| Melting Point | 137-140 |
| Solubility | 0.00001% |
| Ionization Efficiency | 4.39206747 |
| Ionization Efficiency | 2.7 |
| Ionization Efficiency | MeCN (80%) |
| Ionization Efficiency | DOI:10.1002/rcm.8352 |
| Dissociation Constants | 7.6 |
Aripiprazole; 129722-12-9; Abilify; Abilitat; OPC-14597; Abilify Discmelt; aripiprazol; Discmelt; Opc 14597; Aripiprex; Abilify MyCite; OPC 31; OPC-31; Abilify Maintena; 7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone; aripiprazolum
| Reported hazard statements | H301 (62.7%), H302 (35.3%), H361 (15.7%), H413 (13.7%), H226, H290, H311, H315 |
|---|
H301 (62.7%): Toxic if swallowed [Danger Acute toxicity, oral]
H302 (35.3%): Harmful if swallowed [Warning Acute toxicity, oral]
Aripiprazole · CAS 129722-12-9 · C23H27Cl2N3O2. UNII 82VFR53I78. Boiling Point: 139.0-139.5 °C; Melting Point: 137-140; Solubility: 0.00001%.
数据来源:PubChem / Wikidata;与随货 COA 不一致时以 COA 为准。
English page: Aripiprazole